Fundraising Fox
Find your path to Maina
Sign up to see every warm intro you have to Maina
- Paths you didn't know you had: your email and LinkedIn already hold routes to Maina. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Maina Bhaman is a Partner in Sofinnova's Capital Strategy, who joined in 2018 with a background as a healthcare investor. She previously served as director of healthcare investment at Touchstone Innovations (formerly Imperial Innovations) in London and earlier worked in R&D at biotech companies including Celltech and Oxford GlycoSciences. She holds a BSc from the University of Texas at Austin and an MBA from Imperial Business School.
Contact· published on Maina's own website
Invests in
BiotechMedical Devices
Deals · 1
Mediar TherapeuticsBoard seat
via Sofinnova Partners · filed Dec 2025 · $75.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Akamis BioAutifony TherapeuticsCatamaran BioCinCor PharmaDisco PharmaceuticalsElevaraEnyo PharmaKuur TherapeuticsMironid LtdMyricx BioNuagePurespringPurespring TherapeticsSitryx TherapeuticsTopiVert
Sources: SEC Form D filings · curated public sources · the firm's website.
Colleagues at Sofinnova Partners
Frequently asked questions
- Who is Maina Bhaman?
- Maina Bhaman is a Partner in Sofinnova's Capital Strategy, who joined in 2018 with a background as a healthcare investor. She previously served as director of healthcare investment at Touchstone Innovations (formerly Imperial Innovations) in London and earlier worked in R&D at biotech companies including Celltech and Oxford GlycoSciences. She holds a BSc from the University of Texas at Austin and an MBA from Imperial Business School.
- Where does Maina Bhaman work?
- Maina Bhaman is Partner at Sofinnova Partners.
- What does Maina Bhaman invest in?
- Maina Bhaman invests in Biotech, Medical Devices.
- What check size does Maina Bhaman write?
- Maina Bhaman typically writes checks of $100K – $5M.
- What boards does Maina Bhaman sit on?
- Maina Bhaman holds tracked board seats at Mediar Therapeutics.
- What companies has Maina Bhaman invested in?
- Investments tracked here include Akamis Bio, Autifony Therapeutics, Catamaran Bio, CinCor Pharma, Disco Pharmaceuticals, Elevara, Enyo Pharma, Kuur Therapeutics, Mediar Therapeutics, Mironid Ltd, Myricx Bio, Nuage, and 4 more.
About this profile. Compiled from public sources — Sofinnova Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights